|
Volumn 39, Issue 6, 2010, Pages
|
Reversal of Dose-Limiting Carboplatin-Induced Peripheral Neuropathy with TRPM8 Activator, Menthol, Enables Further Effective Chemotherapy Delivery
a,b b b a a a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
CA 125 ANTIGEN;
CARBOPLATIN;
MENTHOL;
PACLITAXEL;
TRANSIENT RECEPTOR POTENTIAL CHANNEL M8;
AGED;
ALLODYNIA;
ANALGESIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PAIN;
CANCER PATIENT;
CANCER STAGING;
CASE REPORT;
DIABETES MELLITUS;
DRUG DOSE INCREASE;
EVENING DOSAGE;
FEMALE;
HAND PARESTHESIA;
HUMAN;
LETTER;
MULTIPLE CYCLE TREATMENT;
NECK PAIN;
NEUROTOXICITY;
OVARY CANCER;
PAIN ASSESSMENT;
PARESTHESIA;
PERIPHERAL NEUROPATHY;
TREATMENT RESPONSE;
VISUAL ANALOG SCALE;
WEAKNESS;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
FEMALE;
HUMANS;
METHANOL;
OVARIAN NEOPLASMS;
PACLITAXEL;
PAIN MEASUREMENT;
PERIPHERAL NERVOUS SYSTEM DISEASES;
TRPM CATION CHANNELS;
|
EID: 77953109127
PISSN: 08853924
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpainsymman.2010.02.004 Document Type: Letter |
Times cited : (30)
|
References (2)
|